Saul Rosenberg Inducted to Giants of Cancer Care® Recognition Program
Saul Rosenberg, MD, Maureen Lyles D’Ambrogio professor emeritus, has been inducted into the 2019 Giants of Cancer Care® program in recognition of his achievements in oncology care, specifically his use of curative chemoradiation to treat lymphoma. This distinguished and highly regarded program honors medical professionals who have made notable contributions to the field of oncology through their research and clinical practice.
Rosenberg is one of 15 2019 inductees who were celebrated at the Giants of Cancer Care® ceremony in May. Award recipients undergo a rigorous selection process beginning with a nomination by peers in the oncology community. Next, a seven-member advisory board of world-renowned oncologists names a list of finalists who are divided into 15 categories based on their specialties. The final nominees are then voted on by a 115-plus member committee comprised of the world’s top oncologists.
A well-respected leader in the oncology community, Rosenberg has pioneered advances in diagnosing, treating and understanding lymphoma, including his work spearheading interdisciplinary clinical investigations on chemotherapy dosage and minimal radiotherapy. His innovative approach to research has been adopted by scientists around the world and his discoveries serve as a foundation for the development of new therapies for a once fatal disease.
Rosenberg served as president of the American Society of Clinical Oncology from 1982 to 1983 and also as chair of the medical oncology subcommittee for the American Board of Internal Medicine.